Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Mesenchymal Stem Cells for Periodontal Tissue Regeneration
jRCTb070230008Completed
- Start
- Apr 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous mesenchymal stem cells in gingival disease. Primary endpoints: Probing depth and Serious adverse events. Started Apr 2023; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
gingival disease
Beyond the preview
Go deeper on jRCTb070230008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTb070230008.